← Back to headlines
Insight Molecular Diagnostics Outlines $2B Market Opportunity for GraftAssureDx
Insight Molecular Diagnostics has outlined a $2 billion annual market opportunity for its product GraftAssureDx, signaling a rapid commercialization push for the diagnostic.
27 Mar, 00:06 — 27 Mar, 00:06
Sources
Showing 1 of 1 sources
